All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Invisible focusable element for fixing accessibility issue
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
ASRS 2024: FARETINA-DME Study
5 months ago
ophthalmologytimes.com
Biosimilars in Retinal Diseases
Dec 8, 2023
ophthalmologytimes.com
Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg
3 months ago
ophthalmologytimes.com
Vision Outcomes with Light Adjustable Lenses
Oct 10, 2023
ophthalmologytimes.com
AGS 2024: Glaucoma management is all about the patient
10 months ago
ophthalmologytimes.com
IKA 2024: EpiSmart cross-linking for keratoconus
7 months ago
ophthalmologytimes.com
AGS 2024: Laser refractive surgery in high-risk glaucoma suspects
10 months ago
ophthalmologytimes.com
MOA of Faricimab and 2-Year Data Review
Aug 30, 2022
ophthalmologytimes.com
This Week in Ophthalmology: Week of November 25, 2024
3 weeks ago
ophthalmologytimes.com
EyeCon 2024: Program co-chair Peter J. McDonnell, MD, marvels o
…
7 months ago
ophthalmologytimes.com
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce tre
…
1 month ago
ophthalmologytimes.com
Absolute Contraindications to Intravitreal Injection and Managin
…
Jul 27, 2022
ophthalmologytimes.com
Anthony Wallace of Bausch Lomb talks about enVista Envy FDA app
…
2 months ago
ophthalmologytimes.com
VR approach to treating amblyopia in children with Luminopia
5 months ago
ophthalmologytimes.com
This Week in Ophthalmology: Week of November 18, 2024
1 month ago
ophthalmologytimes.com
AAO 2024: Energy drinks and central retinal vein occlusions
2 months ago
ophthalmologytimes.com
ASRS 2024: LUNA phase 2 interim data
5 months ago
ophthalmologytimes.com
AAO 2023: Neurotech's encapsulated cell therapy, NT-501
Nov 9, 2023
ophthalmologytimes.com
ASRS 2024: Data from the CALM registry study
5 months ago
ophthalmologytimes.com
Real World Ophthalmology: A day packed with insights, innovation,
…
Sep 20, 2023
ophthalmologytimes.com
Part 8: Advice from the experts: Helpful information for current res
…
2 weeks ago
ophthalmologytimes.com
Part 3: Advice from the experts: Helpful information for current res
…
3 weeks ago
ophthalmologytimes.com
Eyecon 2024: Thyroid Eye Disease in focus
2 months ago
ophthalmologytimes.com
SLT as First-line Treatment for Glaucoma
5 months ago
ophthalmologytimes.com
Visus Therapeutics CEO announces acquisition of ViewPoint Therapeu
…
Sep 30, 2022
ophthalmologytimes.com
ASCRS 2024: An update from ViaLase on its technology for a no
…
8 months ago
ophthalmologytimes.com
ASCRS 2024: George O. Waring IV, MD, shares early results of bilater
…
8 months ago
ophthalmologytimes.com
ASRS 2024: Neurotech Pharmaceuticals update on the N
…
5 months ago
ophthalmologytimes.com
Retina Society 2024: A comparison of tyrosine kinase inhibitors in de
…
3 months ago
ophthalmologytimes.com
AAO 2023: OTT166 progress: OcuTerra's diabetic retinopathy tr
…
Nov 3, 2023
ophthalmologytimes.com
See more videos
More like this
Feedback
Feedback